J-Pharma Co., Ltd.

¥332.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:520AHealthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (73.01%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap ¥5.997B
ROIC (68.64%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥413
24.53%
(57.96%)
Hold 6|11|2|2|5
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
4.18
4.23
4.33
4.69
23.66%
15.68%
20.71%
23.91%
Revenue¥M
268.4
265.8
265.3
266.6
5.27%
(0.01%)
(3.69%)
(3.32%)
Peers (US$38.07M)
Cap (US$)
PE
38.31M
—
37.98M
—
Capital
TTM
5Y
10Y
Leveragex
2.907
0.054
0.048
EBIT/Intx
2.080
1.456
1.295
Own earn%
48.30
(22.36)
(19.79)
Sh yield%
22.64
32.37
33.53
Owners
Insiders/Inst%
12.95
66.66
Short interest%
4.80
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
7